Geneticure Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Series A
  • (Upcoming)

  • Investors
  • 6

Geneticure General Information

Description

Developer of pharmacogenomic tools designed to predict treatment methods for chronic and dangerous diseases. The company's tools are used in multi-gene, disease-specific genomic panels, supported by clinical evidence that helps doctors and clinicians create personalized, patient-specific treatments for controlling blood pressure and hypertension, enabling patients to have painless, affordable at-home tests to monitor their blood pressure.

Contact Information

Website
www.geneticure.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4 3rd Street Southwest
  • Suite 305b
  • Rochester, MN 55902
  • United States
+1 (800)
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 4 3rd Street Southwest
  • Suite 305b
  • Rochester, MN 55902
  • United States
+1 (800)

Geneticure Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Geneticure Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC (Series A) Upcoming Generating Revenue
12. Later Stage VC 21-Oct-2026 Completed Generating Revenue
11. Secondary Transaction - Private Completed Generating Revenue
10. Accelerator/Incubator 01-Jan-2026 Completed Generating Revenue
9. Accelerator/Incubator 12-Jul-2023 Completed Generating Revenue
8. Later Stage VC Completed Generating Revenue
7. Grant 27-Apr-2020 Completed Generating Revenue
6. Seed Round 01-Apr-2018 Completed Generating Revenue
5. Seed Round 17-Aug-2017 $2.1M $3.24M Completed Generating Revenue
4. Seed Round 18-Oct-2016 $952K $1.14M Completed Generating Revenue
To view Geneticure’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Geneticure Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of pharmacogenomic tools designed to predict treatment methods for chronic and dangerous diseases. The company
Diagnostic Equipment
Rochester, MN
9 As of 2023

King of Prussia, PA
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Geneticure Competitors (8)

One of Geneticure’s 8 competitors is Genomind, a Venture Capital-Backed company based in King of Prussia, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genomind Venture Capital-Backed King of Prussia, PA
Precision Diagnostics (San Diego) Private Equity-Backed San Diego, CA
Myriad Genetics Corporation Salt Lake City, UT
OneOme Formerly VC-backed Minneapolis, MN
OmeCare Formerly VC-backed San Diego, CA
You’re viewing 5 of 8 competitors. Get the full list »

Geneticure Patents

  • 10

    Total Documents Applications and Grants

  • Total Patents Families

  • 5

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Geneticure Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4132653-A1 Genetic method for diagnosis and treatment of pre and post coronavirus infections Inactive 11-Apr-2020
EP-4132653-A4 Genetic method for diagnosis and treatment of pre and post coronavirus infections Inactive 11-Apr-2020
US-20240002935-A1 Genetic method for diagnosis and treatment of pre and post coronavirus infections Pending 11-Apr-2020
WO-2021207587-A1 Genetic method for diagnosis and treatment of pre and post coronavirus infections Inactive 11-Apr-2020
EP-3728637-A1 Method for treatment of hypertension Inactive 21-Dec-2017 C12Q1/6883
To view Geneticure’s complete patent history, request access »

Geneticure Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Geneticure Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Xcellerant Ventures Venture Capital Minority
EmPOWERED to Serve Accelerator/Incubator
Creative Destruction Lab Accelerator/Incubator
Minnesota Department of Employment and Economic Development Government
Wireframe Ventures Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Geneticure FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process